Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: a SPECT study
Abstract
The purpose of this study was to examine the change of dopamine transporters (DAT) binding in methamphetamine (METH) abusers in a two-week period of abstinence and its association with cognitive function. Seven healthy subjects and seven METH abusers were recruited. At baseline conditions, the values of specific uptake ratio (SUR) of DAT binding measured by single photon emission computed tomography were lower in METH abusers than in controls. After a two-week period of abstinence, DAT binding was partially recovered and there were no statistic differences in SUR between METH abusers and controls. There was a borderline correlation between the changes of DAT binding in the right, but not the left, striatum and the %Error of Wisconsin Card Sorting Test. These findings indicate that DAT binding in METH abusers can be reversed in a short period of abstinence. The recovery of DAT binding was asymmetric and possibly parallel with the improvement of cognitive function.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Methamphetamine abusers show a consistent and long-lasting decrease in the dopamine transporter, the main target of methamphetamine.
“Alternatively, studies in methamphetamine abusers show a consistent and long lasting decrease in the dopamine transporter, which is the main target of this drug (Chou et al., 2007; Johanson et al., 2006; McCann et al., 1998; McCann et al., 2008; Sekine et al., 2001; Volkow et al., 2001b).”
From Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity (2014) · cites this paper as Chou et al., 2007
Cites
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Leonido–Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., HITZEMANN, R. J., Ding, Y. ‐., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984 · see citing works
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L. L., Wang, G., Fowler, J. S., Franceschi, D., Sedler, M. J., Gatley, S. J., Miller, E. N., HITZEMANN, R. J., Ding, Y., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754 · see citing works
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
Wilson, J. M., Kalasinsky, K. S., Levey, A. I., Bergeron, C., Reiber, G. D., Anthony, R. M., Schmunk, G. A., Shannak, K. S., Haycock, J. W., & Kish, S. J. (1996) · Nature Medicine · doi:10.1038/nm0696-699 · Cited by 718 · see citing works
Sekine, Y., Iyo, M., Ouchi, Y., Matsunaga, T., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., Takei, N., & Mori, N. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1206 · Cited by 408 · see citing works
Innis, R. B., Seibyl, J. P., Scanley, B. E., Laruelle, M. A., Abi‐Dargham, A., Wallace, E. A., Baldwin, R. M., Zea‐Ponce, Y., Zoghbi, S. S., & Wang, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11965 · Cited by 359 · see citing works
Frost, J. J., Rosier, A., Reich, S. G., Smith, J. S., Ehlers, M., Snyder, S. H., Ravert, H. T., & Dannals, R. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340331 · Cited by 320 · see citing works
Striatal dopamine transporters and cognitive functioning in healthy men and women
Mozley, L. H., Gur, R. C., Mozley, P. D., & Gur, R. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1492 · Cited by 314 · see citing works
Rapid and Reversible Effects of Methamphetamine on Dopamine Transporters
Fleckenstein, A. E., Metzger, R. R., Wilkins, D. G., Gibb, J. W., & Hanson, G. R. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36858-2 · Cited by 233 · see citing works
Imaging of dopamine transporters in humans with technetium-99m TRODAT 1
Kung, H. F., Kim, H. J., Kung, M., Meegalla, S. K., Plöessl, K., & Lee, H. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254479 · Cited by 225 · see citing works
Relapse of Paranoid Psychotic State in Methamphetamine Model of Schizophrenia
Sato, M., Numachi, Y., & Hamamura, T. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.1.115 · Cited by 222 · see citing works
Booij, J., Habraken, J. B. A., Bergmans, P., Tissingh, G., Winogrodzka, A., Wolters, E. C., Janssen, A. G. M., Stoof, J. C., & van Royen, E. A. (1998) · PubMed · Cited by 178 · see citing works
Mozley, P. D., Schneider, J. S., Acton, P. D., Plößl, K., Stern, M. B., Siderowf, A. D., Leopold, N. A., Li, P. Y., Alavi, A. A., & Kung, H. F. (2000) · PubMed · Cited by 174 · see citing works
[ 99m Tc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent
Kung, M., Stevenson, D. A., Pl�ssl, K., Meegalla, S. K., Beckwith, A. W., Essman, W. D., Mu, M., Lucki, I., & Kung, H. F. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00881808 · Cited by 162 · see citing works
Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
Huang, W.-S., Lin, S., Lin, J.-C., Wey, S., Ting, G., & Liu, R. (2001) · PubMed · Cited by 142 · see citing works
Laakso, A., Vilkman, H., Alakare, B., Haaparanta, M., Bergman, J., Solin, O., Peurasaari, J., Räkköläinen, V., Syvälahti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.269 · Cited by 138 · see citing works
Neurotoxic Amphetamine Analogues: Effects in Monkeys and Implications for Humansa
Ricaurte, G. A., & McCann, U. D. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24586.x · Cited by 126 · see citing works
Melega, W. P., Raleigh, M. J., Stout, D. B., Laćan, G., Huang, S.-C., & Phelps, M. E. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00548-9 · Cited by 126 · see citing works
Halldin, C., Erixon-Lindroth, N., Pauli, S., Chou, Y.-H., Okubo, Y., Karlsson, P., Lundkvist, C., Olsson, H., Guilloteau, D., Emond, P., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1212-3 · Cited by 110 · see citing works
Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen, K., Lu, C., Yen, T. C., Wey, S., & Ting, G. (2001) · PubMed · Cited by 105 · see citing works
Drago, J., Padungchaichot, P., Accili, D., & Fuchs, S. (1998) · Developmental Neuroscience · doi:10.1159/000017313 · Cited by 101 · see citing works
Dopamine and cognitive functioning: Brain imaging findings in Huntington’s disease and normal aging
Bäckman, L., & Farde, L. (2001) · Scandinavian Journal of Psychology · doi:10.1111/1467-9450.00238 · Cited by 96 · see citing works
Tiihonen, J., Vilkman, H., Räsänen, P., Ryynänen, O.-P., Hakko, H., Bergman, J., Hämäläinen, T., Laakso, A., Haaparanta-Solin, M., Solin, O., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000365 · Cited by 79 · see citing works
Brunswick, D. J., Benmansour, S., Tejani‐Butt, S. M., & Hauptmann, M. (1992) · Synapse · doi:10.1002/syn.890110404 · Cited by 75 · see citing works
Bustamante, D., You, Z., Castel, M., Johansson, S., Goiny, M., Terenius, L. Y., Hökfelt, T. G. M., & Herrera‐Marschitz, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01171.x · Cited by 74 · see citing works
Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia
Akiyama, K., Kanzaki, A., Tsuchida, K., & Ujike, H. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90035-3 · Cited by 70 · see citing works
Ricaurte, G. A., Mechan, A. O., Yuan, J. X., Hatzidimitriou, G., Xie, T., Mayne, A. H., & McCann, U. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087916 · Cited by 67 · see citing works
Acton, P. D., Kushner, S. A., Kung, M., Mozley, P. D., Plöessl, K., & Kung, H. F. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050420 · Cited by 57 · see citing works
Development of Tc-99m labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent
Kung, H. F. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00220-7 · Cited by 50 · see citing works
Sandoval, V., Hanson, G. R., & Fleckenstein, A. E. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00871-2 · Cited by 43 · see citing works
Stefański, R., Lee, S. H., Yaşar, S., Cadet, J. L., & Goldberg, S. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01301-8 · Cited by 42 · see citing works
Kinetic modeling of [99mTc]TRODAT-1: a dopamine transporter imaging agent.
Kushner, S. A., McElgin, W., Kung, M. P., Mozley, P. D., Plößl, K., Meegalla, S. K., Mu, M., Dresel, S. H. J., Vessotskie, J. M., Lexow, N., et al. (1999) · PubMed · Cited by 33 · see citing works
Varrone, A., Fujita, M., Verhoeff, N. P. L. G., Zoghbi, S. S., Baldwin, R. M., Rajeevan, N., Charney, D. S., Seibyl, J. P., & Innis, R. B. (2000) · PubMed · Cited by 24 · see citing works
Flagged first, then by citations
6 of the 38 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A review of the clinical pharmacology of methamphetamine.
Cruickshank, C., & Dyer, K. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 747 · see citing works
Neurocognitive Effects of Methamphetamine: A Critical Review and Meta-analysis
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant, I. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9031-0 · Cited by 669 · see citing works
Ashok, A. H., Mizuno, Y., Volkow, N. D., & Howes, O. D. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0135 · Cited by 330 · see citing works
An Evaluation of the Evidence that Methamphetamine Abuse Causes Cognitive Decline in Humans
Dean, A. C., Groman, S. M., Morales, A. M., & London, E. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.179 · Cited by 251 · see citing works
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
London, E. D., Kohno, M., Morales, A. M., & Ballard, M. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.044 · Cited by 187 · see citing works
Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs
Booij, J., & Kemp, P. M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0621-0 · Cited by 175 · see citing works
Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity
Trifilieff, P., & Martinez, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.031 · Cited by 171 · see citing works
Moszczyńska, A., & Callan, S. P. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.238501 · Cited by 133 · see citing works
Simon, S. L., Dean, A. C., Cordova, X., Monterosso, J. R., & London, E. D. (2010) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2010.71.335 · Cited by 117 · see citing works
Iudicello, J. E., Woods, S. P., Vigil, O., Scott, J. C., Cherner, M., Heaton, R. K., Atkinson, J. H., Grant, I., & Ce, T. H. N. R. (2010) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903512637 · Cited by 111 · see citing works
Pharmacotherapeutic agents in the treatment of methamphetamine dependence
Morley, K. C., Cornish, J. L., Faingold, A., Wood, K., & Haber, P. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1313229 · Cited by 108 · see citing works
Bertolino, A., Fazio, L., Giorgio, A. D., Blasi, G., Romano, R., Taurisano, P., Caforio, G., Sinibaldi, L., Ursini, G., Popolizio, T., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4858-08.2009 · Cited by 101 · see citing works
Boileau, I., Rusjan, P., Houle, S., Wilkins, D., Tong, J., Selby, P., Guttman, M., Saint-Cyr, J. A., Wilson, A. A., & Kish, S. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3008-08.2008 · Cited by 100 · see citing works
Psychostimulant use and the brain
Lappin, J., & Sara, G. E. (2019) · Addiction · doi:10.1111/add.14708 · Cited by 97 · see citing works
Brain serotonin transporter in human methamphetamine users
Kish, S. J., Fitzmaurice, P. S., Boileau, I., Schmunk, G. A., Ang, L.-C., Furukawa, Y., Chang, L., Wickham, D. J., Sherwin, A. L., & Tong, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1346-x · Cited by 93 · see citing works
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84 · see citing works
Methamphetamine use and future risk for Parkinson’s disease: Evidence and clinical implications
Lappin, J., Darke, S. G., & Farrell, M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.02.032 · Cited by 80 · see citing works
Volkow, N. D., Wang, G., Smith, L. A., Fowler, J. S., Telang, F., Logan, J., & Tomasi, D. G. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.07.035 · Cited by 75 · see citing works
Kish, S. J., Boileau, I., Callaghan, R. C., & Tong, J. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13363 · Cited by 67 · see citing works
Imaging Cognitive Deficits in Drug Abuse
Lundqvist, T. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_26 · Cited by 64 · see citing works
Graham, D. L., Noailles, P.-A. H., & Cadet, J. L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05269.x · Cited by 58 · see citing works
Proebstl, L., Kamp, F., Manz, K., Krause, D., Adorjan, K., Pogarell, O., Koller, G., Soyka, M., Falkai, P., & Kambeitz, J. (2019) · European psychiatry · doi:10.1016/j.eurpsy.2019.03.003 · Cited by 52 · see citing works
He, W., Wang, J., & Tsai, P. (2021) · Neurorehabilitation and neural repair · doi:10.1177/1545968321104131 · Cited by 50 · see citing works
Chou, Y. H., Wang, S., Lin, C., Mao, W., Lee, S., & Liao, M. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00800.x · Cited by 49 · see citing works
Imaging the Neurochemistry of Alcohol and Substance Abuse
Martínez, D., Kim, J., Krystal, J. H., & Abi‐Dargham, A. (2007) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2007.07.004 · Cited by 49 · see citing works
Zhou, Y., Sun, M., Li, H., Yan, M., He, Z., Wang, W., Wang, W., & Lu, S. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.01.007 · Cited by 42 · see citing works
Chahid, Y., Sheikh, Z. H., Mitropoulos, M., & Booij, J. (2023) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06171-x · Cited by 39 · see citing works
Chou, Y.-H., Wang, S.-J., Lirng, J.-F., Lin, C.-L., Yang, K., Chen, C., Yeh, C., & Liao, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.043 · Cited by 37 · see citing works
Urban, N., & Martínez, D. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2012.03.011 · Cited by 33 · see citing works
Imaging the serotonin transporter using 123I-ADAM in the human brain
Chou, Y.-H., Yang, B., Chung, M., Chen, S.-P., Su, T., Chen, C., & Wang, S.-J. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.12.006 · Cited by 31 · see citing works
Imaging Procedure and Clinical Studies of [18F]FP-CIT PET
Sung, C., Oh, S. J., & Kim, J. S. (2024) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-024-00840-x · Cited by 29 · see citing works
Zhang, M., Zhao, D., Zhang, Z., Cao, X., Yin, L., Liu, Y., Yuan, T., & Luo, W. (2019) · Science Advances · doi:10.1126/sciadv.aax6916 · Cited by 29 · see citing works
Neuroimaging biomarkers of addiction
Ekhtiari, H., Sangchooli, A., Carmichael, O. T., Moeller, F. G., O’Donnell, P., Oquendo, M. A., Paulus, M. P., Pizzagalli, D. A., Ramey, T., Schacht, J. P., et al. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00334-x · Cited by 28 · see citing works
Hsu, J.-W., Lirng, J., Wang, S., Lin, C.-L., Yang, K., Liao, M., & Chou, Y. H. (2013) · Bipolar Disorders · doi:10.1111/bdi.12164 · Cited by 27 · see citing works
Hammers, D. B., & Suhr, J. A. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390903379599 · Cited by 24 · see citing works
Ezzatpanah, Z., Shariat, S. V., & Tehrani‐Doost, M. (2014) · Europe PMC (PubMed Central) · Cited by 24 · see citing works
Chou, Y.-H., Hsieh, W.-C., Chen, L.-C., Lirng, J.-F., & Wang, S.-J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.056 · Cited by 23 · see citing works
Striatal Reinnervation Process after Acute Methamphetamine-Induced Dopaminergic Degeneration in Mice
Granado, N., Ares‐Santos, S., Tizabi, Y., & Moratalla, R. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9925-z · Cited by 22 · see citing works
Yuan, J., Lv, R., Brašić, J. R., Han, M., Liu, X., Wang, Y., Zhang, G., Liu, C., Li, Y., & Deng, Y. (2013) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2013.11.005 · Cited by 20 · see citing works
Hayley, A. C., Shiferaw, B. A., & Downey, L. A. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101929 · Cited by 18 · see citing works
Pilhatsch, M., Pooseh, S., Junke, A., Kohno, M., Petzold, J., Sauer, C., & Smolka, M. N. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.588768 · Cited by 17 · see citing works
Zhuang, W., Tang, Y., Zhong, N., Jiang, H., Du, J., Wang, J., & Zhao, M. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9673-x · Cited by 16 · see citing works
Jalayeri, Z., Rajabzadeh, A., Hosseini, M., Beheshti, F., & Ebrahimzadeh‐Bideskan, A. (2017) · Anatomical Science International · doi:10.1007/s12565-017-0419-5 · Cited by 16 · see citing works
Chen, Y., Wang, L., Lin, S., & Chen, C. (2015) · Substance Use & Misuse · doi:10.3109/10826084.2015.1050110 · Cited by 14 · see citing works
Bernhardt, N. R., Petzold, J., Groß, C., Scheck, A., Pooseh, S., Mayer-Pelinski, R., Zimmermann, U. S., Smolka, M. N., & Pilhatsch, M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00581 · Cited by 14 · see citing works
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study
Wang, T., Fan, T., Lappin, J., Li, X., Zhao, Y., Wu, P., Shi, J., Bao, Y., & Lü, L. (2021) · American Journal on Addictions · doi:10.1111/ajad.13209 · Cited by 12 · see citing works
Yang, K., Ku, H., Wu, C., Wang, S.-J., Yang, C., Deng, J., Lee, M., & Chou, Y.-H. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.006 · Cited by 12 · see citing works
Yang, K., Wang, S.-J., Hsieh, W.-C., Lirng, J.-F., Yang, C., Deng, J., Lin, C.-L., & Chou, Y.-H. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.12.002 · Cited by 12 · see citing works
Yeh, C., Chou, Y.-H., Cheng, C., Lee, M., Wang, J., Lee, C.-H., Shiue, C., Su, T., & Huang, W.-S. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.07.004 · Cited by 12 · see citing works
Impulse Inhibition Ability With Methamphetamine Dependents Varies at Different Abstinence Stages
Liu, W., Tian, Y., Yan, X., & Yang, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.626535 · Cited by 13 · see citing works
Cognition during active methamphetamine use versus remission
Huckans, M. S., Boyd, S. J., Moncrief, G. G., Hantke, N. C., Winters, B., Shirley, K., Sano, E., McCready, H. D., Dennis, L. E., Kohno, M., et al. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.1976734 · Cited by 12 · see citing works
Yang, K., Yang, B., Lirng, J.-F., Liu, M., Hu, L., Liou, Y., Chan, L.-A., & Chou, Y.-H. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.11.002 · Cited by 10 · see citing works
Zhang, S., Yang, W., Li, M., Wang, S., Zhang, J., Liu, J., & Yuan, K. (2022) · Brain Imaging and Behavior · doi:10.1007/s11682-022-00721-x · Cited by 10 · see citing works
Hsu, J.-W., Wang, S.-J., Lin, C.-L., Hsieh, W.-C., Lirng, J.-F., Shen, Y., Liao, M., & Chou, Y.-H. (2011) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.011 · Cited by 10 · see citing works
The Pathology of Methamphetamine Use in the Human Brain
Kish, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00008-3 · Cited by 10 · see citing works
Permpoonputtana, K., Namyen, J., Buntup, D., Boontem, P., Nopparat, C., & Govitrapong, P. (2025) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.24.1236 · Cited by 9 · see citing works
Chiu, Y.-C., Yang, B., Yang, K., Liu, M., Hu, L., Liou, Y., Chan, L.-Y., & Chou, Y.-H. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111296 · Cited by 9 · see citing works
Fitzpatrick, R. E., Robinson, A. H., Rubenis, A. J., Lubman, D. I., & Verdejo‐García, A. (2021) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2020.1869243 · Cited by 9 · see citing works
Aggression in bipolar II disorder and its relation to the serotonin transporter
Chou, Y.-H., Lin, C.-L., Wang, S.-J., Lirng, J.-F., Yang, K., Chang, A. C., & Liao, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.007 · Cited by 9 · see citing works
Cherner, M., Watson, C. W.-M., Saloner, R., Halpin, L. E., Minassian, A., Murray, S. S., Vaida, F., Bousman, C., & Everall, I. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.06.012 · Cited by 8 · see citing works
Granado, N., Mendieta, L., Tizabi, Y., Murer, M. G., & Moratalla, R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106839 · Cited by 6 · see citing works
Complete and Readily Reversible Blocking of Striatal DaTscan Binding by Methylphenidate
Cheng, G., & Morley, J. F. (2013) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000307 · Cited by 5 · see citing works
Role of Dopamine Transporter in the Relationship Between Plasma Cortisol and Cognition
Yang, K., Liu, M., Yang, B., & Chou, Y.-H. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001089 · Cited by 5 · see citing works
The modern trends in alcohol, drugs and driving research
Raes, E., Pil, K., & Verstraete, A. (2009) · Forensic science international supplement series · doi:10.1016/j.fsisup.2009.07.004 · Cited by 5 · see citing works
Mehrjerdi, Z. A., Noroozi, A., Barr, A. M., & Ekhtiari, H. (2012) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 5 · see citing works
Asghar, E., Vahid, S. S., & Farahani, H. (2012) · Advances in Cognitive Science · Cited by 4 · see citing works
Neurochemical Imaging of Addictive Disorders
Broft, A. I., & Martínez, D. (2012) · Neuromethods · doi:10.1007/7657_2012_48 · Cited by 4 · see citing works
Abnormalities of Neurotransmission in Drug Addiction
Trick, L., Butler, K., Chukwueke, C. C., Ciano, P. D., Ibrahim, C., Rubin-Kahana, D. S., Boileau, I., & Foll, B. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_21 · Cited by 4 · see citing works
A Roller Coaster from Methamphetamine to Ketamine
Huang, M., Lin, S., & Chen, C. (2014) · 臺灣精神醫學 · Cited by 2 · see citing works
Zhang, S., Li, M., Wang, S., Zhang, J., Liu, J., & Yuan, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1788658/v1 · Cited by 2 · see citing works
Neurochemical Imaging in Addiction
Wai, J. M., LEVIN, F. R., & Martínez, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00001-8 · Cited by 1 · see citing works
Mehrjerdi, Z. A., Kiakojouri, A., & Dolan, K. A. (2014) · Cited by 1 · see citing works
Methamphetamine withdrawal: clinical profile, assessment and treatment
Cruickshank, C. (2010) · UWA Profiles and Research Repository (UWA)
Wu, C., Yang, K., Wang, S.-J., & Chou, Y.-H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.009
Cognitive Function Evaluation by Mini-Mental State Examination-Korea in Essential Blepharospasm
Chung, S. J., & Lew, H. (2013) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2013.54.6.857
Rezaee, M., Bigdeli, I., & Makvand, S. (2017) · مجله مطالعات ناتوانی (علمی- پژوهشی)
- Authors
- Chou, Y.-H., Huang, W.-S., Su, T.-P., Lu, R.-B., Wan, F.-J., & Fu, Y.-K.
- Affiliations
- Taipei Veterans General Hospital (TW)
- Tri-Service General Hospital (TW)
- National Cheng Kung University (TW)
- Institute of Nuclear Energy Research (TW)
- Corresponding author
- Chou, Yuan-Hwa
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 17
- Issue
- 1
- Pages
- 46-52
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2125964893
- Cited by
- 78
- References
- 38
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 4 · 2014: 6 · 2013: 7 · 2012: 9
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- dopamine transporter, methamphetamine, abstinence, cognitive function, striatum, Wisconsin Card Sorting Test, hemispheric lateralization, single photon emission computed tomography
- MeSH terms
- Adult, Brain Mapping, Cognition, Humans, Male, Methamphetamine, Radiochemistry, Triterpenes, Reproducibility of Results, Tomography, Emission-Computed, Single-Photon, Dopamine Uptake Inhibitors, Amphetamine-Related Disorders, Dopamine Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
